8-K: Safety Shot Secures $250,000 in Private Placement, Issues Shares at 20% Discount

Safety Shot, Inc. has entered into a Securities Purchase Agreement with an accredited investor to raise $250,000 through the sale of 844,594 common shares at a 20% discount to the market price.

Summary

• Safety Shot, Inc. (the "Company") entered into a Securities Purchase Agreement (SPA) on July 3, 2025, with one accredited investor.
• The Company sold 844,594 shares (PIPE Shares) to the investor for gross proceeds of $250,000.
• The purchase price per share was $0.296, representing a 20% discount off the closing price on July 3, 2025.
• The shares are registered under an effective registration statement (File No. 333-267644, effective November 9, 2022) and will be issued free of any restrictions on sale.
• The Company intends to use the net proceeds for general corporate purposes, including working capital, and potentially acquisitions.
• The Company is required to maintain its Nasdaq listing and apply to list the newly issued shares.
• The Company acknowledges potential dilution from the issuance of these securities.

Sentiment

Score: 6

Explanation: The capital raise provides necessary funding, which is positive for the company's operations and liquidity. However, the significant discount and explicit acknowledgment of potential substantial dilution introduce a negative aspect for existing shareholders. The overall sentiment is neutral to slightly positive, as securing funding is critical, but the terms are not ideal.

Positives

• Secured $250,000 in gross proceeds, providing additional capital for general corporate purposes and working capital.
• The shares are registered and will be issued free of restrictions on sale, which is favorable for the investor.
• The Company represents that it is solvent and will remain so after the transaction.
• The Company is in material compliance with Sarbanes-Oxley and SEC reporting requirements.

Negatives

• The shares were sold at a $0.296 per share, representing a 20% discount to the closing price on July 3, 2025, which could be dilutive to existing shareholders.
• The Company explicitly acknowledges that the issuance of the Securities may result in substantial dilution of the outstanding shares of Common Stock.

Risks

• Potential for substantial dilution of outstanding common stock due to the issuance of new shares at a discount.
• Risk of Public Information Failure, where the Company would incur liquidated damages (1.0% of aggregate Subscription Amount every 30 days) if it fails to satisfy public information requirements under Rule 144(c) or other filing obligations.
• The Company's ability to maintain its Nasdaq listing is crucial, as a failure could impact the trading of its stock.
• The Company's obligations under the Transaction Documents are unconditional and absolute, regardless of dilutive effects or claims the Company may have against the Purchaser.

Future Outlook

The Company intends to use the net proceeds from this capital raise for general corporate purposes, including working capital, and may also use funds for acquisitions at its discretion. The Company also commits to maintaining its Nasdaq listing and ensuring the newly issued shares are listed for trading.

Management Comments

• The Company acknowledges that the issuance of the Securities may result in dilution of the outstanding shares of Common Stock, which dilution may be substantial under certain market conditions.
• The Company further acknowledges that its obligations under the Transaction Documents, including, without limitation, its obligation to issue the Shares pursuant to the Transaction Documents, are unconditional and absolute and not subject to any right of set off, counterclaim, delay or reduction, regardless of the effect of any such dilution or any claim the Company may have against the Purchaser and regardless of the dilutive effect that such issuance may have on the ownership of the other stockholders of the Company.

Industry Context

This private placement reflects a common strategy for smaller public companies to raise capital quickly from institutional or accredited investors, often at a discount, to fund operations or strategic initiatives. The use of proceeds for general corporate purposes and potential acquisitions suggests a focus on growth or sustaining current operations within its industry.

Stakeholder Impact

• Shareholders: Potential for dilution due to the issuance of new shares at a discount.
• Company Operations: Improved liquidity and working capital for general corporate purposes and potential acquisitions.

Next Steps

• The Company will file a Current Report on Form 8-K, including the Transaction Documents as exhibits.
• The Company will issue a press release disclosing the material terms of the transaction.
• The Company will apply to list all newly issued shares on its principal Trading Market (Nasdaq).
• The Company will continue to maintain the listing or quotation of its Common Stock on the Trading Market.
• The Purchaser will make payment for the common stock within two business days of the Closing Date.

Key Dates

Recommendation

Keywords

Safety Shot, SHOT, Securities Purchase Agreement, Private Placement, PIPE, Common Stock, Capital Raise, Dilution, SEC Filing, 8-K, Nasdaq, Accredited Investor, Working Capital